154 related articles for article (PubMed ID: 29687367)
1. Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer.
Lv Z; Yan X; Lu L; Su C; He Y
J Bioenerg Biomembr; 2018 Aug; 50(4):263-270. PubMed ID: 29687367
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity.
Wang Y; Xie F; Chen D; Wang L
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):890-897. PubMed ID: 31209921
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
Tian S; Chen H; Tan W
Biochem Biophys Res Commun; 2018 May; 499(4):1019-1024. PubMed ID: 29630860
[TBL] [Abstract][Full Text] [Related]
6. Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.
Xiang M; Kim H; Ho VT; Walker SR; Bar-Natan M; Anahtar M; Liu S; Toniolo PA; Kroll Y; Jones N; Giaccone ZT; Heppler LN; Ye DQ; Marineau JJ; Shaw D; Bradner JE; Blonquist T; Neuberg D; Hetz C; Stone RM; Soiffer RJ; Frank DA
Blood; 2016 Oct; 128(14):1845-1853. PubMed ID: 27531676
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evidence of synergism between atovaquone and chemotherapy by AMPK-dependent mitochondrial dysfunction.
Xie F; Gong J; Tan H; Zhang H; Ma J
Eur J Pharmacol; 2021 Sep; 907():174256. PubMed ID: 34129882
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Wnt Signaling by Atovaquone Inhibits Gastric Cancer and Enhances Chemotherapy Effectiveness Through Activation of Casein Kinase 1α.
Shang R; Liao Y; Zheng X
Nutr Cancer; 2024; 76(5):452-462. PubMed ID: 38494910
[TBL] [Abstract][Full Text] [Related]
9. Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration.
Guo Y; Hu B; Fu B; Zhu H
Pathol Res Pract; 2021 Aug; 224():153529. PubMed ID: 34174549
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells.
Lepore SM; Maggisano V; Lombardo GE; Maiuolo J; Mollace V; Bulotta S; Russo D; Celano M
Endocr Metab Immune Disord Drug Targets; 2019; 19(1):59-66. PubMed ID: 30264682
[TBL] [Abstract][Full Text] [Related]
12. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
13. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone.
Cheng G; Hardy M; Topchyan P; Zander R; Volberding P; Cui W; Kalyanaraman B
Sci Rep; 2020 Oct; 10(1):17872. PubMed ID: 33087770
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cysts.
Enkai S; Inaoka DK; Kouguchi H; Irie T; Yagi K; Kita K
Parasitol Int; 2020 Apr; 75():102004. PubMed ID: 31678356
[TBL] [Abstract][Full Text] [Related]
16. Zinc improves mitochondrial respiratory function and prevents mitochondrial ROS generation at reperfusion by phosphorylating STAT3 at Ser
Zhang G; Sheng M; Wang J; Teng T; Sun Y; Yang Q; Xu Z
J Mol Cell Cardiol; 2018 May; 118():169-182. PubMed ID: 29605530
[TBL] [Abstract][Full Text] [Related]
17. Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respiration and AMPK/mTOR Signaling.
Li Y; Sun Q; Chen S; Yu X; Jing H
Anticancer Agents Med Chem; 2022; 22(14):2539-2547. PubMed ID: 35168524
[TBL] [Abstract][Full Text] [Related]
18. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
Wang W; Zhou J; Zhao L; Chen S
Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.
Skwarski M; McGowan DR; Belcher E; Di Chiara F; Stavroulias D; McCole M; Derham JL; Chu KY; Teoh E; Chauhan J; O'Reilly D; Harris BHL; Macklin PS; Bull JA; Green M; Rodriguez-Berriguete G; Prevo R; Folkes LK; Campo L; Ferencz P; Croal PL; Flight H; Qi C; Holmes J; O'Connor JPB; Gleeson FV; McKenna WG; Harris AL; Bulte D; Buffa FM; Macpherson RE; Higgins GS
Clin Cancer Res; 2021 May; 27(9):2459-2469. PubMed ID: 33597271
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.
Zhou J; Ong CN; Hur GM; Shen HM
Biochem Pharmacol; 2010 May; 79(9):1242-50. PubMed ID: 20026083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
